MBX · Categories · Form 4

MBX - SEC Form 4 insider transactions

MBX Biosciences Inc. (MBX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for MBX

• 3d
  SEC Form 4 filed by Director Mathers Edward T

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 4d
  SEC Form 4 filed by Director Pescovitz Ora H.

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 4d
  SEC Form 4 filed by Director Heron Patrick J

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 4d
  SEC Form 4 filed by Director Stelzer Laurie

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 4d
  SEC Form 4 filed by Director Hoerter Steven L.

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 4d
  SEC Form 4 filed by Director Ryder Steven

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 4d
  SEC Form 4 filed by Director Aynechi Tiba

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 28d
  Chief Medical Officer Azoulay Salomon exercised 70,003 shares at a strike of $11.65 and sold $2,685,515 worth of shares (70,003 units at $38.36) as part of a pre-agreed trading plan (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 31d
  Chief Medical Officer Azoulay Salomon sold $6,824 worth of shares (231 units at $29.54), decreasing direct ownership by 2% to 14,769 units (SEC Form 4) (withholding obligation)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 31d
  President & CEO Hawryluk P. Kent sold $17,931 worth of shares (607 units at $29.54), decreasing direct ownership by 0.08% to 727,667 units (SEC Form 4) (for withholding tax)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 36d
  Director Hoerter Steven L. was granted 11,938 shares (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 48d
  Amendment: SEC Form 4 filed by Hoerter Steven L.

  4/A - MBX Biosciences, Inc. (0001776111) (Issuer)
• 48d
  Amendment: SEC Form 4 filed by Hoerter Steven L.

  4/A - MBX Biosciences, Inc. (0001776111) (Issuer)
• 101d
  President & CEO Hawryluk P. Kent exercised 28,768 shares at a strike of $16.00, increasing direct ownership by 4% to 728,274 units (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 125d
  Chief Medical Officer Azoulay Salomon was granted 15,000 shares (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 125d
  Chief Financial Officer Bartram Richard was granted 15,000 shares (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 125d
  President & CEO Hawryluk P. Kent was granted 35,250 shares, increasing direct ownership by 5% to 699,506 units (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 137d
  SEC Form 4 filed by Director Stelzer Laurie

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 195d
  SEC Form 4 filed by Director Hoerter Steven L.

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 213d
  SEC Form 4 filed by Director Hoerter Steven L.

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 224d
  President & CEO Hawryluk P. Kent exercised 182,859 shares at a strike of $3.25, increasing direct ownership by 38% to 664,256 units (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 367d
  SEC Form 4 filed by Director Mathers Edward T

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 368d
  SEC Form 4 filed by Director Hoerter Steven L.

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 368d
  SEC Form 4 filed by Director Aynechi Tiba

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 368d
  SEC Form 4 filed by Director Cornelius James M

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 368d
  SEC Form 4 filed by Director Ryder Steven

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 368d
  SEC Form 4 filed by Director Heron Patrick J

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 368d
  SEC Form 4 filed by Director Pescovitz Ora H.

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 426d
  SEC Form 4 filed by Director Hoerter Steven L.

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 488d
  SEC Form 4 filed by Chief Medical Officer Azoulay Salomon

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 488d
  SEC Form 4 filed by Chief Financial Officer Bartram Richard

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 629d
  Director Cornelius James M converted options into 102,082 shares (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 629d
  President & CEO Hawryluk P. Kent converted options into 399,760 shares, increasing direct ownership by 144% to 481,397 units (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 629d
  Large owner Wellington Biomedical Innovation Master Investors (Cayman) Ii L.P. converted options into 1,790,122 shares (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)

Other MBX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends